ArticlePloS one2016

MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.

Shuit-Mun Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.